Rayaldee is now approved! Visit the new Rayaldee Web Site  

Promoting Health through Vitamin D Therapeutics

Improving People's Lives by Treating and Preventing the Clinical Consequences of
Vitamin D Insufficiency and Secondary Hyperparathyroidism


Recent News:

FDA Authorizes OPKO Health Clinical Trial Evaluating RAYALDEE in COVID-19 Patients
June 01, 2020

OPKO Health Reports Interim Results for Two Ongoing RAYALDEE Studies
March 25, 2020

OPKO Health Announces Appointment of Patricia Sandler as National Sales Director for Rayaldee
July 19, 2019




© 2020 OPKO Health Inc.- All rights reserved. | Privacy Policy | Terms Of Use